# A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

> **NCT07487727** · PHASE3 · RECRUITING · sponsor: **Kind Pharmaceuticals LLC** · enrollment: 240 (estimated)

## Conditions studied

- Anemia Due to Chronic Kidney Disease

## Interventions

- **DRUG:** AND017
- **DRUG:** ESA

## Key facts

- **NCT ID:** NCT07487727
- **Lead sponsor:** Kind Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487727, "A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07487727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*